Business Description
Ebos Group Ltd
ISIN : NZEBOE0001S6
Share Class Description:
NZSE:EBO: Ordinary SharesCompare
Compare
Traded in other countries / regions
EBO.New ZealandEBO.AustraliaEJG.GermanyEBOSF.USA IPO Date
1960-12-01Description
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 3.14 | |||||
| Interest Coverage | 6.27 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.22 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | 11 | |||||
| 3-Year FCF Growth Rate | 8.1 | |||||
| 3-Year Book Growth Rate | 16.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.16 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.26 | |||||
| 9-Day RSI | 58.17 | |||||
| 14-Day RSI | 53.24 | |||||
| 6-1 Month Momentum % | 3.19 | |||||
| 12-1 Month Momentum % | -22.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.24 | |||||
| Quick Ratio | 0.74 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 40.88 | |||||
| Days Sales Outstanding | 42.27 | |||||
| Days Payable | 72.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.22 | |||||
| Dividend Payout Ratio | 0.72 | |||||
| 3-Year Dividend Growth Rate | 11 | |||||
| Forward Dividend Yield % | 3.22 | |||||
| 5-Year Yield-on-Cost % | 5.05 | |||||
| 3-Year Average Share Buyback Ratio | -5.7 | |||||
| Shareholder Yield % | 2.08 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.6 | |||||
| Operating Margin % | 3.78 | |||||
| Net Margin % | 2.03 | |||||
| FCF Margin % | 1.81 | |||||
| ROE % | 10.88 | |||||
| ROA % | 3.95 | |||||
| ROIC % | 8.5 | |||||
| ROC (Joel Greenblatt) % | 46.89 | |||||
| ROCE % | 11.45 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.18 | |||||
| Forward PE Ratio | 22.78 | |||||
| PE Ratio without NRI | 23.28 | |||||
| Shiller PE Ratio | 30.63 | |||||
| Price-to-Owner-Earnings | 18.8 | |||||
| PEG Ratio | 1.86 | |||||
| PS Ratio | 0.49 | |||||
| PB Ratio | 2.67 | |||||
| Price-to-Free-Cash-Flow | 27.1 | |||||
| Price-to-Operating-Cash-Flow | 18.49 | |||||
| EV-to-EBIT | 17.1 | |||||
| EV-to-Forward-EBIT | 14.91 | |||||
| EV-to-EBITDA | 13.31 | |||||
| EV-to-Forward-EBITDA | 12.39 | |||||
| EV-to-Revenue | 0.61 | |||||
| EV-to-Forward-Revenue | 0.61 | |||||
| EV-to-FCF | 33.48 | |||||
| Price-to-Projected-FCF | 1.56 | |||||
| Price-to-DCF (Earnings Based) | 1.48 | |||||
| Price-to-DCF (FCF Based) | 1.68 | |||||
| Price-to-Median-PS-Value | 1.23 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.89 | |||||
| Earnings Yield (Greenblatt) % | 5.85 | |||||
| FCF Yield % | 3.68 | |||||
| Forward Rate of Return (Yacktman) % | 15.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ebos Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NZ$) | 13,822.477 | ||
| EPS (TTM) (NZ$) | 1.466 | ||
| Beta | 0.47 | ||
| Volatility % | 20.73 | ||
| 14-Day RSI | 53.24 | ||
| 14-Day ATR (NZ$) | 0.725439 | ||
| 20-Day SMA (NZ$) | 34.655 | ||
| 12-1 Month Momentum % | -22.1 | ||
| 52-Week Range (NZ$) | 33.5 - 46 | ||
| Shares Outstanding (Mil) | 191.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ebos Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ebos Group Ltd Stock Events
| Event | Date | Price(NZ$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ebos Group Ltd Frequently Asked Questions
What is Ebos Group Ltd(NZSE:EBO)'s stock price today?
The current price of NZSE:EBO is NZ$35.45. The 52 week high of NZSE:EBO is NZ$46.00 and 52 week low is NZ$33.50.
When is next earnings date of Ebos Group Ltd(NZSE:EBO)?
The next earnings date of Ebos Group Ltd(NZSE:EBO) is 2024-08-23 Est..
Does Ebos Group Ltd(NZSE:EBO) pay dividends? If so, how much?
The Dividend Yield %  of Ebos Group Ltd(NZSE:EBO) is 3.22% (As of Today), Highest Dividend Payout Ratio of Ebos Group Ltd(NZSE:EBO) was 0.74. The lowest was 0.54. And the median was 0.67. The  Forward Dividend Yield % of Ebos Group Ltd(NZSE:EBO) is 3.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers